Commentary on “Vogt–Koyanagi–Harada Syndrome Following COVID-19 mRNA Vaccination: Th2 to Th1 Transition-related Molecular Machinery”
Acta Dermato-Venereologica · 2024
DOI: 10.2340/actadv.v104.40781 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Dermato-Venereologica, 2024. Verfasst von Hinpetch Daungsupawong und 1 weiteren Autor:innen. Beteiligte Einrichtung: Private Academic Consultant, Phonhong, Lao People's Democratic Republic. hinpetchdaung@gmail.com. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, Th1 Cells, Th2 Cells. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
is missing (Correspondence)
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Private Academic Consultant, Phonhong, Lao People's Democratic Republic. hinpetchdaung@gmail.com.
- Department of Research Analytics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences Saveetha University, Chennai, India.
ORCID-Profile: Hinpetch Daungsupawong, Viroj Wiwanitkit
Zitieren
APA
Daungsupawong, H., & Wiwanitkit, V. (2024). Commentary on “Vogt–Koyanagi–Harada Syndrome Following COVID-19 mRNA Vaccination: Th2 to Th1 Transition-related Molecular Machinery”. Acta Dermato-Venereologica. https://doi.org/10.2340/actadv.v104.40781
Vancouver
Daungsupawong H, Wiwanitkit V. Commentary on “Vogt–Koyanagi–Harada Syndrome Following COVID-19 mRNA Vaccination: Th2 to Th1 Transition-related Molecular Machinery”. Acta Dermato-Venereologica. 2024. doi:10.2340/actadv.v104.40781
BibTeX
@article{Daungsupawong2024,
author = {Daungsupawong, Hinpetch and Wiwanitkit, Viroj},
title = {Commentary on “Vogt–Koyanagi–Harada Syndrome Following COVID-19 mRNA Vaccination: Th2 to Th1 Transition-related Molecular Machinery”},
journal = {Acta Dermato-Venereologica},
year = {2024},
doi = {10.2340/actadv.v104.40781}
}
EUVIMED